Here is a look at Alzheimer’s disease, a progressive brain disorder that leads to loss of memory and other intellectual abilities. Facts Alzheimer’s disease is the most common form of dementia, which ...
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
Eli Lilly shares first human trial results for LOXO-435, a selective FGFR3 inhibitor for bladder cancer, showing 41% response ...
PORTLAND, OR, UNITED STATES, February 15, 2025 /EINPresswire / -- Ankylosing spondylitis (AS) is a chronic inf ...
Hosted on MSN9h
Johnson & Johnson Highlights Promising Data on Investigational Autoantibody Drug NipocalimabHOUSE, PA — Johnson & Johnson has unveiled groundbreaking findings on nipocalimab, an investigational FcRn blocker, in a recent publication in mAbs. The study showcases the drug’s high-affinity ...
Bamlanivimab and etesevimab combination has been authorised under Emergency Use Authorisation in the US and select EU countries for the treatment of the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback